GlassScriptPhysician profile
Audrey R Fuller
NPI 1104462316
$8,122.03
in general payments reported to CMS, 2019-2025
51 companies · $1,242 in 2025
The $1,242 reported for 2025 was more than what 88% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $996 · 2022: $2,281 · 2023: $2,646 · 2024: $958 · 2025: $1,242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,845.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,845.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $888.24 | 2021-2025 | Mounjaro, Jardiance, Trulicity |
| Novo Nordisk INC | $882.68 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbott Laboratories | $706.24 | 2021-2025 | Freestyle Libre 3 |
| Xeris Pharmaceuticals, INC. | $598.94 | 2021-2025 | Recorlev, Gvoke Hypopen |
| Mannkind Corporation | $565.28 | 2021-2025 | Afrezza |
| Insulet Corporation | $524.30 | 2021-2025 | Omnipod, Omnipod |
| Corcept Therapeutics | $460.64 | 2021-2025 | Korlym |
| Tandem Diabetes Care, INC. | $448.04 | 2021-2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Abbvie INC. | $303.02 | 2021-2024 | |
| Dexcom, INC. | $280.70 | 2021-2025 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $222.57 | 2022-2024 | |
| Radius Health, INC. | $200.79 | 2021-2024 | Tymlos |
| Cequr Corporation | $194.14 | 2023-2025 | Cequr Simplicity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $162.20 | 2021-2024 | Jardiance, Synjardy, Tradjenta |
| Amgen INC. | $141.29 | 2021 |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $138.46 | 2023-2025 | Entyvio, Ninlaro |
| Amneal Pharmaceuticals LLC | $125.67 | 2023-2025 | Unithroid |
| Beta Bionics, INC. | $118.43 | 2023 | Ilet Bionic Pancreas |
| Sequel Med Tech, LLC | $99.29 | 2025 | Twiist |
| Pfizer INC. | $86.28 | 2021-2023 | |
| Bigfoot Biomedical INC | $81.35 | 2022 | |
| Ibsa Pharma INC. | $57.50 | 2022-2023 | Tirosint, Licart |
| Glaxosmithkline, LLC. | $56.11 | 2023 | Shingrix, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $51.32 | 2022-2025 | |
| Amphastar Pharmaceuticals, INC. | $49.65 | 2025 | |
| Ultragenyx Pharmaceutical INC. | $49.26 | 2022-2023 | |
| Astellas Pharma US INC | $48.95 | 2023-2024 | Veozah, Myrbetriq |
| Chiesi USA, INC. | $40.85 | 2025 | Mycapssa |
| Halozyme INC | $34.92 | 2023 | |
| Dynavax Technologies Corporation | $33.47 | 2023 | Heplisav-B |
| Idorsia Pharmaceuticals US INC | $32.73 | 2023-2024 | Quviviq |
| Ascendis Pharma Endocrinology INC | $32.44 | 2025 | Yorvipath |
| Merck Sharp & Dohme LLC | $31.10 | 2023 | Dificid |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.04 | 2023 | Cycloset |
| Astrazeneca Pharmaceuticals LP | $29.13 | 2021-2022 | |
| Davol INC. | $28.93 | 2025 | |
| Acera Surgical, INC. | $25.52 | 2025 | Restrata Wound Matrix |
| Lundbeck LLC | $25.23 | 2024 | Vyepti |
| Incyte Corporation | $22.38 | 2024 | Jakafi |
| Novartis Pharmaceuticals Corporation | $21.85 | 2022 | |
| Novocure INC. | $20.82 | 2025 | Optune Lua (Novottf-200t) |
| Antares Pharma, INC. | $20.28 | 2024 | Xyosted |
| Tempus Ai, INC | $19.80 | 2025 | Xt Cdx |
| Avion Pharmaceuticals | $19.46 | 2023 | Balcoltra |
| Upsher-Smith Laboratories LLC | $17.71 | 2023 | |
| Kerecis Limited | $17.50 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Genentech USA, INC. | $17.01 | 2025 | Lunsumio, Columvi |
| Azurity Pharmaceuticals, INC. | $16.93 | 2023 | Horizant |
| Sandoz INC. | $14.42 | 2025 | Jubbonti |
| Recordati_rare_diseases_inc. | $14.22 | 2025 | Isturisa |
| Exact Sciences Corporation | $13.95 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Audrey Fuller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.